Skip to main content

Table 1 Mean baseline characteristics of TAVI and AVR patients aged ≥ 75 years

From: In-hospital resource utilization in surgical and transcatheter aortic valve replacement

  AVR   TAVI AVR vs. TAVI  
   All TF-TAVI TA-TAVI   TF vs. TA-TAVI
  27   83 60 23 p-value p-value
Demographics           
 Age 78.74 ±3.43 82.9 ±4.48 82.95 ±4.67 82.78 ±4.03 p <0.01 0.963
 Female 44 %   67 %   68 %   65 %   0.029 0.798
Medical History           
 LVEF (%) 50.37 ±12.8 50.52 ±9.62 51.2 ±9.25 48.47 ±10.68 0.785 0.257
 AVA 0.81 ±0.17 0.68 ±0.16 0.68 ±0.17 0.65 ±0.14 p <0.01 0.9796
 Renal diseasea 56 %   64 %   57 %   83 %   0.183 0.043
 CAD 37 %   54 %   55 %   52 %   0.183 1.000
 Previous MI 11 %   22 %   17 %   35 %   0.272 0.084
 Previous PCI 19 %   24 %   23 %   26 %   0.609 0.781
 Previous Stroke 4 %   7 %   5 %   13 %   1.000 0.340
 Previous CABG 4 %   12 %   8 %   22 %   0.288 0.131
 AF 33 %   41 %   33 %   61 %   0.507 0.027
 Hypertension 93 %   83 %   85 %   78 %   0.348 0.518
 DM 33 %   27 %   25 %   30 %   0.623 0.782
 Liver disease 4 %   6 %   5 %   9 %   1.000 0.614
 COPD 11 %   16 %   13 %   22 %   0.757 0.336
 PVD 4 %   20 %   17 %   30 %   0.068 0.224
 Quality of lifeb 0.84 ±0.21 0.79 ±0.21 0.8 ±0.22 0.76 ±0.17 0.062 0.134
 proBNP (pg/ml) 1474 ±1708 4098 ±6576 3820 ±6111 4805 ±7749 0.654 0.760
Risk Scores           
 EuroScore I 10.44 ±6.21 20.66 ±13.05 18.53 ±10.16 25.87 ±17.49 p <0.01 0.065
 EuroScore II 3.54 ±3.15 6.77 ±5.59 5.83 ±4.09 9.04 ±7.84 p <0.01 0.094
 STS-Score 3.48 ±1.57 5.7 ±3.36 5.48 ±2.88 6.21 ±4.35 p <0.01 0.505
  1. Abbreviations: LVEF – left ventricular ejection fraction; AVA – preoperative aortic valve area; CAD – coronary artery disease; MI – myocardial infarction: PCI – percutaneous coronary intervention; AF – atrial fibrillation; DM – diabetes mellitus; COPD – chronic obstructive pulmonary disease; PVD – peripheral vascular disease; proBNP–B-type natiuretic peptide. Data are presented as n (%) or mean ± standard deviation
  2. aRenal disease defined as (glomerular filtration rate <60 ml/h); bPatients quality of life at baseline according to standardized EQ-5D questionnaire